Challenges in the management of sickle cell disease during pregnancy in Senegal, West Africa

Hematology. 2018 Jan;23(1):61-64. doi: 10.1080/10245332.2017.1367534. Epub 2017 Aug 28.

Abstract

Objectives: The aim of this study was to evaluate the maternal and fetal complications in pregnant patients with sickle cell disease (SCD) and find risk factors of stillbirth.

Method: We conducted a prospective study in pregnant women with SCD. Demographic characteristics, maternal and fetal morbi-mortality, and outcome of pregnancies were described. Risk factors of fetal loss were evaluated by comparing the parameters of the pregnancies that led to a live birth with those interrupted.

Results: We included 70 pregnancies in 58 women with SCD. The average age was 29.3 years. The average gestational age at the start of follow-up was 13 weeks. The occurrence of acute complications was significantly higher during pregnancy compared to the year before (p < 0.05). Maternal mortality was 0%. Live birth rate was 80%. Fetal loss rate was 3.9 times higher in previous pregnancies that had not been monitored in hematology (71.8 versus 18.6%). Stillbirth was associated with nulliparity, high leukocytes or platelet counts (p < 0.05).

Conclusion: Pregnancy in SCD was associated with a high maternal morbidity and stillbirth. Nulliparity, high leucokocytes or platelet count were identified as risk factors of fetal loss.

Keywords: Sickle-cell disease; fetal loss; morbidity; mortality; pregnancy; risk factors.

MeSH terms

  • Adult
  • Africa, Western
  • Anemia, Sickle Cell / complications
  • Anemia, Sickle Cell / pathology
  • Anemia, Sickle Cell / therapy*
  • Female
  • Humans
  • Pregnancy
  • Prospective Studies
  • Risk Factors